Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artichoke Extract for Mesothelioma Chemoprevention (ABOCA1)
NCT02076672Phase 2Completed
- Sponsor
- Ontario Clinical Oncology Group
- Start
- Nov 2019
- Primary completion
- Apr 2020
- Countries
- 1
01
Overview
Phase 2, open-label trial in mesothelioma, sponsored by Ontario Clinical Oncology Group. Primary endpoint: Serum Mesothelin at 90 days. Started Nov 2019; status: completed.
02
Conditions
mesothelioma
Beyond the preview
Go deeper on NCT02076672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02076672.